how the mpn field has evolved over the years: novel agents, trials, and more
Published 1 year ago • 172 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:31
novel treatment agents and how they're changing the mpn field
-
1:13
ongoing trials in wm, where the field is moving, and the growing role of novel agents
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
1:05
moving the mpn field forward
-
1:47
the role of ngs in improving diagnosis in mpns
-
2:43
the management of advanced phase mpns
-
1:33
mympn: a patient registry removing bias from mpn research
-
6:15
how to manage and report aes associated with bispecific antibody treatment in myeloma
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:28
how to approach the treatment of younger patients with mpn
-
1:30
advancements in prognostication tools in mpns in recent years
-
1:27
ash 2023: what to look forward to in the mpn space
-
2:09
heart transplantation in attr amyloidosis
-
1:39
germline predisposition to clonal hematopoiesis and its role in leukemia progression
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
1:56
ongoing and future trials in mpn-ap/bp
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:00
getting involved in real-world studies for cll through eric